Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New synthetic anti-TB drug from a rediscovered natural cyclic peptide

Sep. 25, 2014

Researchers describe the function of MS susceptibility gene

Sep. 25, 2014

alpha-Amino-beta-lactam carbamates as systemic NAAA inhibitors

Sep. 25, 2014

Once-weekly GH replacement therapy with MOD-4023 shows promise in pediatric patients

Sep. 23, 2014

AGI-12026, a novel potent and selective IDH2 R140Q inhibitor shows promise in vivo

Sep. 23, 2014

Adenium Biotech presents a novel antibacterial peptide for Gram-negative bacteria

Sep. 23, 2014

GeNeuro presents novel clinical and preclinical results for GNbAC-1

Sep. 23, 2014

Preclinical and phase I results presented for LY-2452473

Sep. 23, 2014

Direct inhibition of InhA to combat drug-resistant TB

Sep. 23, 2014

Research looks into role of betatrophin in human diabetes and its potential as a biomarker

Sep. 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026